A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β(2)-Agonist (LABA) Combinations in COPD

INTRODUCTION: Comparative data on the efficacies of long-acting muscarinic antagonist (LAMA) and long-acting β(2)-agonist (LABA) combinations for the treatment of moderate-to-very-severe chronic obstructive pulmonary disease (COPD) are limited. The aim of this Bayesian network meta-analysis (NMA) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Sion, Katya Y. J., Huisman, Eline L., Punekar, Yogesh S., Naya, Ian, Ismaila, Afisi S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964204/
https://www.ncbi.nlm.nih.gov/pubmed/32026346
http://dx.doi.org/10.1007/s41030-017-0048-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964204/
https://www.ncbi.nlm.nih.gov/pubmed/32026346
http://dx.doi.org/10.1007/s41030-017-0048-0

Ejemplares similares